ClinicalTrials.Veeva

Menu

Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery (PECUR)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Mortality
VV-ECMO
Emergency Surgery
ECMO Outcomes
ARDS
Propensity Score Matching
Retrospective Cohort
Thoracic Surgery

Study type

Observational

Funder types

Other

Identifiers

NCT07016685
PI2025_843_0071

Details and patient eligibility

About

Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).

Enrollment

380 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults ≥ 18 years
  • VV-ECMO initiated during or after emergency thoracic surgery
  • No opposition to data use

Exclusion criteria

  • Pregnant women
  • Veno-Arterial ECMO patients
  • Patients under legal protection

Trial design

380 participants in 2 patient groups

VV-ECMO after emergency thoracic surgery
Description:
VV-ECMO after emergency thoracic surgery
VV-ECMO for medical ARF
Description:
VV-ECMO for medical indication

Trial contacts and locations

1

Loading...

Central trial contact

Christophe Beyls, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems